本页面由Tiger Trade Technology Pte. Ltd.提供服务

Taysha Gene Therapies, Inc.

6.27
-0.0300-0.48%
成交量:280.22万
成交额:1,766.55万
市值:18.01亿
市盈率:-18.39
高:6.52
开:6.25
低:6.11
收:6.30
52周最高:6.76
52周最低:1.85
股本:2.87亿
流通股本:1.85亿
量比:1.23
换手率:1.51%
股息:- -
股息率:- -
每股收益(TTM):-0.3409
每股收益(LYR):-0.3409
净资产收益率:-68.45%
总资产收益率:-27.42%
市净率:7.29
市盈率(LYR):-18.39

数据加载中...

2026/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/19

重要事件披露

Form 8-K - Current report
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report